Skip to main content
. 2021 Feb 19;11:603594. doi: 10.3389/fimmu.2020.603594

Table 1.

Demographics and clinical characteristics of HD patients and healthy controls.

HD group Healthy control group p value
N 33 33 NA
M:F 15:18 15:18 NA
Age (y/o) 42.6 (12.7)a 48.0 (13.5)a 0.0967*
BMI (kg/m2) 21.3 (3.7)a 24.0 (3.6)a 0.003*
HD duration(y) 4.0 (7.0)b NA NA
CAG repeat number 42.0 (3.5)b NA NA
UHDRS-M 35.0 (70.0)b NA NA
FAS scores 21.0 (11.0)b NA NA
TFC scores 12.0 (10.0)b NA NA
SIT scores 18.0 (16.0)b NA
SDMT scores 21.0 (25.0)b NA
CFT scores 11.0 (11.0)b NA
BDI-II scores 6.0 (15.0)b NA
MMSE scores 28.0 (5.0)b NA

*Unpaired t-test; the data are presented as the mean (SD)a or median (IQR)b; HD, Huntington’s disease; NA, not applicable; SD, standard deviation; IQR, interquartile range; M:F, male: female; y, years; y/o, years old; BMI, body mass index; UHDRS-M, motor section of Unified Huntington’s Disease Rating Scale; FAS, Functional Assessment Scale; TFC, Total Functional Capacity; SIT, Stroop Interference Test; SDMT, Symbol Digit Modalities Test; CFT, Category Fluency Test; BDI-II, Beck Depression Inventory II; MMSE, Mini-Mental State Examination.